Tentative Topics
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Effective Use of Student-Created Case Studies As Assessment in an Undergraduate Neuroscience Course
The Journal of Undergraduate Neuroscience Education (JUNE), Spring 2021, 19(2):A141-A162 ARTICLE Effective Use of Student-Created Case Studies as Assessment in an Undergraduate Neuroscience Course Dianna M. Bindelli1*, Shannon A.M. Kafura1*, Alyssa Laci1*, Nicole A. Losurdo1*, Denise R. Cook-Snyder1,2 *These authors have contributed equally to this work; 1Neuroscience Department, Carthage College, Kenosha, WI 53140; 2Department of Physiology, Medical College of Wisconsin, Milwaukee WI 53226. Case studies and student-led learning activities are both exchanged case studies with their peers, and both taught effective active learning methods for increasing student and completed the case studies as low-stakes assessment. engagement, promoting student learning, and improving Student performance and evaluations support the efficacy of student performance. Here, we describe combining these case studies as assessment, where iterative writing instructional methods to use student-created case studies improved student performance, and students reported as assessment for an online neurovirology module in a increased knowledge and confidence in the corresponding neuroanatomy and physiology course. First, students learning objectives. Overall, we believe that using student- learned about neurovirology in a flipped classroom format created case studies as assessment is a valuable, student- using free, open-access virology resources. Then, students led extension of effective case study pedagogy, and has used iterative writing practices to write an interrupted -
Community Pride Honoring the Behind-The-Scene Supporters Research Support Comes Innovative Projects Forward, As Well As Ventured Into New Areas of Research
Front Line news from the Department of Pharmacology and Experimental Neuroscience Community Pride Honoring the behind-the-scene supporters Research support comes innovative projects forward, as well as ventured into new areas of research. in many forms including In 2006, department chairman Howard grants from the National E. Gendelman, M.D., hosted the first Institutes of Health (NIH) Community Pride in Neuroscience Lecture and Dinner to recognize the and other federal agencies, outstanding support and generosity of not-for-profit foundations, these individuals and to recognize out- and industry sponsors. standing scientists in the field of neu- roscience. Now, in its fourth year, the two-day event kicks off with a lecture by But, what happens to research ideas an international scientist, followed by when such funding is not available? meetings of faculty and students and Thanks to the generosity of a quiet a dinner honoring the distinguished group of individuals, the Department scientist and community members. of Pharmacology and Experimental This year the lives of lifelong Nebraska Neuroscience at the University of Nebraska Medical Center has moved see Community Pride pg 6 Two Neuroscience Centers In June two neuroscience center’s established in 1997 under Howard were approved. The Center for E. Gendelman, M.D. The Center Neurodegenerative Disorders and the for Integrative and Translational Center for Integrative and Translational Neuroscience, directed by Howard Neuroscience will both explore the S. Fox, M.D., Ph.D., is the link be- causes of neurodegenertive diseases to tween basic science discoveries and improve diagnostics and potential drug translational implementation in the therapies. -
A Healthcare Provider's Guide to HIV
A Healthcare Provider’s Guide to HIV-Associated Neurocognitive Disorder (HAND): Diagnosis, pharmacologic management, non-pharmacologic management, and other considerations This material is provided by UCSF Weill Institute for Neurosciences as an educational resource for health care providers. Models for illustrative purposes only. A Healthcare Provider’s Guide to HIV-Associated Neurocognitive Disorder (HAND) A Healthcare Provider’s Guide To HIV-Associated Neurocognitive Disorder (HAND): Diagnosis, pharmacologic management, non-pharmacologic management, and other considerations Diagnosis Definition Risk Factors People living HIV may develop a spectrum of cognitive, motor, Risk factors for developing HAND include lack of viral suppression, and/or mood problems collectively known as HIV-Associated low nadir CD4 count, and increasing age.2,3,4 Additional risk Neurocognitive Disorder (HAND). Typical symptoms include factors may include medical comorbidities such as hypertension, difficulties with attention, concentration, and memory; loss of hyperlipidemia, diabetes, and possible co-infections like motivation; irritability; depression; and slowed movements. hepatitis C.5 There may also be host factors that make certain Previously known as AIDS Dementia Complex, HAND individuals more vulnerable to develop HAND. is categorized into three levels of functional impairment. Asymptomatic Neurocognitive Impairment (ANI) is a mild form Course of HAND with impaired performance on neuropsychological tests, There is no typical course of HAND, and it is not typically thought but affected individuals report independence in performing to be a progressive disorder inevitably leading to dementia. Most of everyday functions. Mild Neurocognitive Disorder (MND) is a the time, HAND symptoms remain mild in patients on ART with an common form of HAND that mildly interferes with everyday undetectable viral load. -
Editors • Neurology: Clinical Practice
Editors • Neurology: Clinical Practice Editor Associate Editors JOHN R. CORBOY, MD, FAAN DAVID C. ANDERSON, MD, FAAN RICHARD BARBANO, MD, PhD, FAAN LUCA BARTOLINI, MD University of Colorado University of Minnesota University of Rochester EDITOR, PRACTICE CURRENT Rochester, NY School of Medicine Saint Paul, MN Clinical Epilepsy Section and Division of Dept. of Neurology & Co-director Specialties: General neurology, stroke, and Specialties: Botulinum toxins, dystonia, Neuroimmunology and Neurovirology Rocky Mountain Multiple Sclerosis medical education movement disorders National Institute of Neurological Center at CU Disorders and Stroke Aurora, CO The Warren Alpert Medical School of Specialties: Neurovirology, multiple sclerosis, Brown University neuroeducation, diagnostics, therapeutics Director, Pediatric Epilepsy Program Providence, RI Specialties: Epilepsy, child neurology, and neuroinflammation ARAVIND GANESH, MD, DPHIL (OXON) GARY R. CUTTER, PhD HAITHAM M. HUSSEIN, MD, MSC DEPUTY EDITOR, PRACTICE CURRENT CONTRIBUTING EDITOR CONTRIBUTING EDITOR Department of Clinical Neurosciences University of Alabama at Birmingham Medical Director Calgary, CANADA School of Public Health Regions Hospital Comprehensive Stroke Specialities: Vascular and cognitive neurology Dept. of Biostatistics Center Birmingham, AL HealthPartners Neurosciences Specialties: Clinical trials, epidemiologic St. Paul, MN studies, and evaluation research Specialties: Behavioral neurology/ neuropsychology, ethics, general neurology, stroke/vascular neurology, clinical trials, imaging, arterial dissection, cerebral venous thrombosis, infarction, intracerebral hemorrhage, subarachnoid hemorrhage, vasculitis, diagnostics, therapeutics 1 Editorial Board • Neurology: Clinical Practice JAMES L. BERNAT, MD, FAAN JOSÉ BILLER, FACP, FAAN MURRAY FLASTER, MD, PhD LYELL K. JONES, JR., MD, BARBARA S. KOPPEL, FAAN Geisel School of Medicine at Loyola University Chicago Lancaster General Hospital MD, FAAN Dartmouth and Dartmouth- Dept. of Neurology Lancaster, PA Dept. of Neurology Dept. -
News in Neurovirology
NEWS IN Spring 2020 • Vol. 16, No. 2 NEUROVIROLOGY Official newsletter of the International Society for NeuroVirology Editor: Tory Johnson, PhD | Associate Editor: Fred Krebs, PhD In this issue: A Message from the President By Bruce Brew A Message The ISNV board and I wanted to address you at this terrible and from the President trying time. Page 1 For those of you who have lost loved ones, our hearts go out to Neurovirology of COVID-19 you. To lose someone you love and yet not be able to be with them at Page 2 their last moments of life is unimaginable. For those of you in lockdown, we understand how frustrating it is to One Neurology Department’s have your work curtailed. Some of you may not be able to carry out any Response to Prepare for laboratory work while others may still be able to do so but to a much COVID-19 lesser extent. Perhaps take this time to re-prioritise your research. As Page 5 summarized in this newsletter, there are many aspects of COVID-19 Research Recommendations that suggest brain involvement but equally there are many unanswered and Funding Opportunities to questions. Clarification of these issues will have direct benefit to address the COVID-19 patients. Pandemic Emergency For those of you in the frontline, we thoroughly support you. Clinical Page 7 laboratory tests and clinical care must continue so that care can be delivered not only to those with COVID-19 infection but also to those COVID-19 quick links who do not, lest they are abandoned, and their illnesses magnify Page 8 through unintentional neglect. -
Cedars-Sinai Neurosciences 2020 Annual Report
CEDARS-SINAI NEUROSCIENCES 2020 ANNUAL REPORT 200513_Neuro_Report_rev2_pro Split.indd 1 5/13/20 5:34 PM 200513_Neuro_Report_rev2_pro Split.indd 2 5/13/20 5:34 PM 1 Dear Colleague, We are delighted to share our annual report with you. As our colleague and supporter, you play an essential role in our current success and ongoing eorts to combat neurological disease and disability. It’s been an extraordinary year. Our departments have made great strides in research and patient care as well as in training the next generation of neurologists and neurosurgeons. Every day, we see our clinicians, researchers and sta embody Cedars-Sinai’s tradition of excellence and compassion. From personalized care to life-changing inventions and discoveries, they make a di erence in the lives of thousands of patients who come to us from throughout the region, the nation and the world. Our commitment and achievements are reected in the many accolades and awards our departments have recently garnered. You can read about them in this report. You will also learn about the breakthroughs we are making in every subspecialty of neurology and neurosurgery. We are honored to present these highlights. Keith Black, MD Nancy Sicotte, MD, FAAN Chair, Department of Chair, Department of Neurosurgery Neurology Ruth and Lawrence Harvey Women’s Guild Chair in Neuroscience Distinguished Chair in Neurology 2020 Annual Report 200513_Neuro_Report_rev2_pro Split.indd 3 5/13/20 5:34 PM 2 2019 HIGHLIGHTS Neurosciences at a Glance Ranking Full-Time Faculty in the nation in Neurology and Neurosurgery No. 12 in U.S. News & World Report 20 Neurosurgery Patient Visits 21 40,000+ Neurosurgery and Neurology Neurology Cedars-Sinai expanded our telestroke program to In June, a gift from the family of the late real help community hospitals provide advanced stroke estate developer Jona Goldrich founded the Jona care at the bedside within minutes. -
Download Dr. Qureshi's CV
Brief Synopsis Nazer H. Qureshi, M.D, D.Stat, M.Sc, DABNS, FAANS. Graduated from Medical School with top honors and first position in Anatomy and Histology in board examinations. Pursued surgical training in Europe including neurosurgery at the National Center for Neurosurgery affiliated with The Royal College of Surgeons of Ireland. In 1994 started as a junior faculty member at University of Dublin teaching medical students while pursuing his own research on “Interleukin-1 binding and expression in brain” towards Masters in Science. During that year also attained a Diploma in Statistics from University of Dublin. In summer of 1995 was a visiting fellow at University of Toronto working on use- dependent inhibitory depression in epilepsy models. In 1996 migrated to US and completed a research fellowship in gene therapy for brain tumors at Harvard Medical School/Massachusetts General Hospital. The work on gene therapy that included testing efficacy and toxicity of different viral vectors and & designing a novel method of gene delivery to human brain tumors culminated into a clinical trial. In 1999 completed a neurosurgery fellowship at University of Arizona. Completed 2 years of accredited General Surgery residency at Tuft’s University and Thomas Jefferson University followed by Neurosurgery Residency in June 2008 from University of Arkansas for Medical Sciences with “Prof. Iftikhar A. Raja Humanity in Medicine Award.” Diplomate American Board of Neurological Surgeons and Fellow of the American Board of Neurological Surgeons. Worked as an attending neurosurgeon at Baptist Hospital Medical Center in Little Rock the chief of brain and spine tumor service at Baptist Health Medical Center, North Little Rock. -
Neurology Resident Handbook 2021-2022
NEUROLOGY RESIDENT HANDBOOK 2021-2022 DEPARTMENT OF NEUROLOGY UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY NEUROLOGY RESIDENT HANDBOOK 2021-2022 DEPARTMENT OF NEUROLOGY UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY Copyright © 2021, by Department of Neurology, University of Rochester FOREWORD This Neurology Resident Handbook is intended as a handy reference for all Neurology clinical faculty, residents and administrative staff. The handbook is divided into seven sections as follows: • ACGME New Accreditation System: This section contains specific program goals and objectives for the neurology residency, the neurology core competencies that are part of the ACGME New Accreditation System, the Neurology Milestones, and descriptions of specific evaluation instruments used to evaluate neurology residents at the University of Rochester. • Research Initiatives and Conferences: This section includes information about the resident research experience and descriptions of several of the neurology conference series. • Inpatient Rotation Guidelines: This section contains guidelines for the neurology residents for all of the core inpatient rotations. • Elective Guidelines: This section contains guidelines for the neurology residents for departmental and inter-departmental electives. • Outpatient Rotation Guidelines: This section contains guidelines for the resident firms and the Chief Resident Faculty Practice clinics. • Policies: This section contains all of the specific policies that involve neurology residents, as mandated by the ACGME. • Bibliography: This section contains a bibliography for adult neurology and should be used as a guide to reading for neurology residents. • Schedules: The final section of this handbook contains all of the rotation and clinic schedules for neurology residents and faculty for the current academic year. The Residency Review Committee for Neurology mandates that we collate all of this information and distribute it annually to all clinical faculty and residents in our department. -
Assessment of Lesions on Magnetic Resonance Imaging in Multiple
doi:10.1093/brain/awz144 BRAIN 2019: 142; 1858–1875 | 1858 REVIEW Assessment of lesions on magnetic resonance Downloaded from https://academic.oup.com/brain/article-abstract/142/7/1858/5519813 by University College London user on 18 October 2019 imaging in multiple sclerosis: practical guidelines Massimo Filippi,1,2,3 Paolo Preziosa,1,3 Brenda L. Banwell,4 Frederik Barkhof,5,6 Olga Ciccarelli,7,8 Nicola De Stefano,9 Jeroen J.G. Geurts,10 Friedemann Paul,11 Daniel S. Reich,12 Ahmed T. Toosy,7 Anthony Traboulsee,13,14 Mike P. Wattjes,15 Tarek A. Yousry,16,17 Achim Gass,18 Catherine Lubetzki,19 Brian G. Weinshenker20 and Maria A. Rocca1,2 MRI has improved the diagnostic work-up of multiple sclerosis, but inappropriate image interpretation and application of MRI diagnostic criteria contribute to misdiagnosis. Some diseases, now recognized as conditions distinct from multiple sclerosis, may satisfy the MRI criteria for multiple sclerosis (e.g. neuromyelitis optica spectrum disorders, Susac syndrome), thus making the diagnosis of multiple sclerosis more challenging, especially if biomarker testing (such as serum anti-AQP4 antibodies) is not informative. Improvements in MRI technology contribute and promise to better define the typical features of multiple sclerosis lesions (e.g. juxtacortical and periventricular location, cortical involvement). Greater understanding of some key aspects of multiple sclerosis pathobiology has allowed the identification of characteristics more specific to multiple sclerosis (e.g. central vein sign, subpial demyelination and lesional rims), which are not included in the current multiple sclerosis diagnostic criteria. In this review, we provide the clinicians and researchers with a practical guide to enhance the proper recognition of multiple sclerosis lesions, including a thorough definition and illustration of typical MRI features, as well as a discussion of red flags suggestive of alternative diagnoses. -
Therapeutic Immunization Protects Dopaminergic Neurons in a Mouse Model of Parkinson’S Disease
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson’s disease Eric J. Benner*†, R. Lee Mosley*†, Chris J. Destache‡, Travis B. Lewis*†, Vernice Jackson-Lewis§, Santhi Gorantla*†, Craig Nemachek*†, Steven R. Green*, Serge Przedborski§¶ʈ, and Howard E. Gendelman*†**†† *Center for Neurovirology and Neurodegenerative Disorders and Departments of †Pathology and Microbiology and **Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198; Departments of §Neurology and ¶Pathology and ʈCenter for Neurobiology and Behavior, Columbia University, New York, NY 10032; and ‡College of Pharmacy, Creighton University, Omaha, NE 68178 Edited by Floyd E. Bloom, The Scripps Research Institute, La Jolla, CA, and approved May 10, 2004 (received for review January 25, 2004) Degeneration of the nigrostriatal dopaminergic pathway, the hall- line-derived neurotrophic factor (GDNF).‡‡ The process was T mark of Parkinson’s disease, can be recapitulated in 1-methyl-4- cell-dependent and led to significant dopaminergic neuronal pro- phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice. Herein, tection. Because no currently clinically approved therapy prevents we demonstrate that adoptive transfer of copolymer-1 immune cells progressive degeneration of dopaminergic neurons in PD, we to MPTP recipient mice leads to T cell accumulation within the suggest that such a vaccination strategy could be of therapeutic substantia nigra pars compacta, suppression of microglial activation, benefit. and increased local expression of astrocyte-associated glial cell line-derived neurotrophic factor. This immunization strategy resulted Materials and Methods in significant protection of nigrostriatal neurons against MPTP- Animals and MPTP Treatment. Male SJL mice (6–10 weeks old, The induced neurodegeneration that was abrogated by depletion of Jackson Laboratory) received four i.p. -
Wcn 2005 Sydney – an Alluring Destination President's
WORLD NEUROLOGY THE NEWSLETTER OF THE WORLD FEDERATION OF NEUROLOGY VOLUME 16, NUMBER 4, DECEMBER 2001 WCN 2005 SYDNEY – AN ALLURING DESTINATION London WCN 2001 was an outstanding Congress not only in terms of venue and attendance, but importantly in terms of the excellence of the scientific compo- nent. The Australian Association of Neu- rologists acknowledges the challenge and importance of ensuring a successful, well- attended meeting. A World Congress pro- vides delegates with the opportunity to establish and build international contacts and keep abreast of international research and we have undertaken to provide a Congress that will be accessible to neu- rologists from all over the World. Having been awarded the honour of host- ing a World Congress, the Australian As- Rocks precinct with heritage buildings post Congress tours, to enable delegates sociation of Neurologists has been given amidst a maze of cobblestone streets, and their partners/families to maximize a unique opportunity to provide a forum unique shops and stunning range of har- their enjoyment of Sydney and Australia. to showcase Australia’s neurological ex- bour-side restaurants, to Darling Harbour pertise and we will ensure delegates ex- with its extensive range of visitor experi- Dr. William Carroll perience a rewarding Congress in terms ences. Realizing that this is a rare oppor- Chairman WCN 2005 of educational and scientific component. tunity for many people to visit Australia, Sydney itself is an exciting, cosmopolitan the Sydney WCN 2005 will offer an en- Prof. Geoffrey Donnan destination with a range of distinct and ticing social and accompanying persons President, Australian Association of diverse characteristics. -
Reports of Wfn-Supported Conferences
WORLD NEUROLOGY THE NEWSLETTER OF THE WORLD FEDERATION OF NEUROLOGY VOLUME 15, NUMBER 1, MARCH 2000 REPORTS OF WFN-SUPPORTED CONFERENCES Xth PAN-AMERICAN CONGRESS OF NEUROLOGY A great success! The Xth Pan-American Congress of Neurology was held from Oc- tober 9–14, 1999, in Cartagena de Indias, Colombia. It was organized by the Colom- bian Neurological Association in associa- tion with WFN. The Organizing Committee was constitut- ed by a select group of Colombian neurol- ogists, in the country and abroad, togeth- er with foreign colleagues and with the great and wise support of the legendary Frank Clifford Rose, former Secre- tary-Treasurer of the WFN. 1051 delegates participated in one of the most beautiful cities of the world and a Historical Herit- age site. The success of the Congress was confirmed during the 6 days by 8 WFN Educational Courses, 19 Symposia, At the 20th Salzburg Conference in Taipei, Taiwan, November 3–6, 1999. 8 Plenary Lectures and 5 Satellite Sympo- sia for a total of 187 presentations by 142 experts from 22 different countries of America, Europe and Asia in the modern tween the speakers and the audience. dent, represented the WFN during the International Convention Center. The Moreover, there were several poster pres- opening and the closing ceremonies of themes included Stroke, Headache, Epi- entations. the Congress. He expressed his gratitude lepsy, Tropical Neurology, Dementia, and congratulations to the members of The Assembly of Pan-American Delegates Movement Disorders and others, that was integrated by 20 countries: Argentina, cont. on page 3 were completed with clinical cases and Bolivia, Brazil, Canada, Colombia, Cuba, videos at the end of each session, allow- Costa Rica, Chile, Ecuador, El Salvador, ing an active academic interaction be- ALSO IN THIS ISSUE: USA, Guatemala, Honduras, Mexico, Pan- ama, Paraguay, Peru, Dominican Repub- New Telephone / Fax lic, Uruguay and Venezuela.